3-methylcholanthrene has been researched along with krn 7000 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forni, G; Hayakawa, Y; Rovero, S; Smyth, MJ | 1 |
Ikarashi, Y; Kato, T; Kuribayashi, K; Nakayama, T; Nishikawa, H; Old, LJ; Saito, K; Shiku, H; Takemitsu, T; Taniguchi, M; Tawara, I; Wakasugi, H; Wang, L | 1 |
2 other study(ies) available for 3-methylcholanthrene and krn 7000
Article | Year |
---|---|
Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fibrosarcoma; Flow Cytometry; Galactosylceramides; Genes, p53; Humans; Interferon-gamma; Interleukin-12; Interleukin-4; Ligands; Methylcholanthrene; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neoplasms; Receptor, ErbB-2; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.
Topics: Animals; Antigens, CD1; Antigens, CD1d; Carcinogens; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Proliferation; Chromium Radioisotopes; Cloning, Molecular; Down-Regulation; Female; Galactosylceramides; Genetic Predisposition to Disease; Killer Cells, Natural; Male; Methylcholanthrene; Mice; Mice, Inbred BALB C; Mice, Transgenic; Neoplasms; Plasmids; Protein Binding; Receptors, Interleukin-2; Recombinant Proteins; T-Lymphocytes; Time Factors | 2005 |